drugset / Trial / NCT05578508

Stem Cells for the Treatment of Pouchitis

NCT05578508 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and feasibility of using allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat people with medically refractory Pouchitis.

Timeline

Start
2022-04
Primary completion
2024-02
Completion
2024-02

Outcome

Outcome not reported

Stopped: “PI decision not to move forward with study.”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesenchymal Stem Cells (MSCs) Cell therapy 6e+07 cells Other